论文部分内容阅读
目的:探讨左卡尼汀联合黄芪注射液治疗小儿病毒性心肌炎的疗效。方法:将64例小儿病毒性心肌炎患者随机分为2组,对照组30例予以常规治疗,治疗组34例在常规治疗基础上加用左卡尼汀和黄芪注射液。结果:治疗后治疗组总有效率94.12%,总有效率73.33%,差异有显著性(P<0.05);治疗组心电图改善情况优于对照组(P<0.05);治疗组CK、CK-MB、LDH较对照组有明显改善(P<0.05)。结论:左卡尼汀联合黄芪注射液应用能明显提高治疗病毒性心肌炎的临床疗效,降低心肌酶。
Objective: To investigate the efficacy of levocarnitine combined with astragalus injection in the treatment of viral myocarditis in children. Methods: 64 cases of children with viral myocarditis were randomly divided into two groups, the control group of 30 patients were routine treatment, the treatment group of 34 patients on the basis of conventional treatment plus levocarnitine and Astragalus injection. Results: After treatment, the total effective rate of the treatment group was 94.12%, the total effective rate was 73.33%, the difference was significant (P <0.05); the improvement of the electrocardiogram of the treatment group was better than that of the control group (P <0.05) , LDH significantly improved compared with the control group (P <0.05). Conclusion: L-carnitine combined with astragalus injection can significantly improve the clinical efficacy of treatment of viral myocarditis, reduce myocardial enzymes.